Cleared Traditional

K080278 - TABATABA COTESTER

K080278 is an FDA 510(k) clearance for TABATABA COTESTER, manufactured by Fim Medical. The device is a Class 2 Anesthesiology device with product code CCJ cleared through the Traditional 510(k) pathway after a 298-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2008
Decision
298d
Days
Class 2
Risk

K080278 is an FDA 510(k) clearance for the TABATABA COTESTER. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Fim Medical (Deer Field, US). The FDA issued a Cleared decision on November 28, 2008 after a review of 298 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K080278

510(k) Number K080278 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2008
Decision Date November 28, 2008
Days to Decision 298 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
158d slower than avg
Panel avg: 140d · This submission: 298d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCJ Device Classification - Class 2, Special Controls

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 22
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K080278.
COSENSE CO MONITOR
K130036 · Capnia, Inc. · Jan 2014
COSENSE
K121768 · Capnia, Inc. · Oct 2012
EC50 MICRO+ SMOKERLYZER
K082315 · Bedfont Scientific, Ltd. · Feb 2010
EC50 TOXCO+ BREATH CARBON MONOXIDE MONITOR
K070259 · Bedfont Scientific, Ltd. · Feb 2008
PICO SMOKERLYZER, MODEL EC-50
K000962 · Bedfont Scientific, Ltd. · Apr 2000
MICROCO
K950197 · Micro Direct, Inc. · Oct 1996